RiverPlus Biotech

African scientists solving an African problem.

We don't study these diseases from a distance. We work where they are.

Team

Small team. Published science. Nothing outsourced.

Lum Abienwi Ambe, PhD

Lum Abienwi Ambe, PhD

Founder & CEO

Cameroonian molecular biologist. Won the grants, ran the research, and delivered the world's first urine antigen dipstick for Riverblindness. 2026 African STARS Fellow.

Mbah Clarisse Engowei, PhD

Mbah Clarisse Engowei, PhD

Clinical & Regulatory Lead

Takes RiverKit through clinical validation and the regulatory path it needs to be used at scale across the continent.

+

Position open

Business Lead

We’re hiring

To take RiverKit from validated prototype to ministries, NGOs and clinics across the continent.

Advisors

Professor Faustin Kamena

Professor Faustin Kamena

Molecular Biology & Parasitology Expert

About

Diagnostics designed for where the patients are.

What we're building

A family of sub-dollar dipsticks for the diseases that actually burden Africa — starting with Riverblindness, designed from day one for the clinic with no electricity.

Why we'll win

We are African scientists solving an African problem from inside it. We know the field conditions, the health systems and the ministries — because we work in them.

Supported & backed by:

Future African ScientistAfrican Research Network for Neglected Tropical DiseasesCOR-NTD — Coalition for Operational Research on Neglected Tropical Diseases